placebo of warfarin

DRUG2 trials

Sponsors

University Hospital, Brest

Conditions

Idiopathic Deep Vein ThrombosisPulmonary EmbolismRecurrent Venous Thromboembolism

Phase 3

Extended Duration of Oral Anticoagulant Therapy After a First Episode of Idiopathic Pulmonary Embolism: a Randomized Controlled Trial. PADIS-PE Study.

CompletedNCT00740883

University Hospital, BrestPulmonary Embolism

Start: 2007-07-31End: 2016-10-31Updated: 2017-01-12

Prolonged Anticoagulation After a First Episod of Idiopathic Proximal Deep Vein Thrombosis (PADIS TVP)

CompletedNCT00740493

University Hospital, BrestIdiopathic Deep Vein Thrombosis, Recurrent Venous Thromboembolism

Start: 2007-07-31End: 2017-01-31Updated: 2017-01-12

Related Papers

Evaluation of Venous Thromboembolism Recurrence Scores in an Unprovoked Pulmonary Embolism Population: A Post-hoc Analysis of the PADIS-PE trial.

2020-04-228 citations

Predictors for Residual Pulmonary Vascular Obstruction after Unprovoked Pulmonary Embolism: Implications for Clinical Practice—The PADIS-PE Trial

Thrombosis and Haemostasis2019-06-2322 citations

Six months <i>versus</i> two years of oral anticoagulation after a first episode of unprovoked deep-vein thrombosis. The PADIS-DVT randomized clinical trial

Haematologica2019-01-0336 citations

Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism

JAMA2015-07-07233 citations

Two Years Versus Six Months of Oral Anticoagulation after a First Episode of Unprovoked Pulmonary Embolism: The Padis PE Multicenter, Double-Blind, Randomized Trial

Blood2014-12-067 citations